Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 2 sources · 12 days · First seen · Last updated
Danish C25 stock index performance
Overview
The Danish C25 index has shown upward movement through late 2026. On October 28, the index remained stable at 1,916.01, representing a 5.04 percent increase since the start of the year. During this period, Genmab shares surged 29.06 percent, contributing to high turnover, while GN Store Nord and Novo Nordisk experienced declines.
By November 9, the index rose to 2,025.43, a 0.82 percent daily increase that brought the year-to-date growth to 11.04 percent. Gains were led by ISS A/S and Genmab. Genmab reported third-quarter revenue growth of 16 percent to 1.187 billion USD and an operating profit of 431 million USD, which exceeded forecasts. Despite these results, the stock showed volatility following its strong yearly performance.
Entities
Novo Nordisk · Genmab · Denmark · C25 · Vestas
Timeline
-
[BUSINESS] 2 sourcesDanish C25 index rises as ISS and Genmab lead gains
The Danish C25 index rose 0.82 percent on Monday, driven by gains in ISS A/S and Genmab, despite mixed results for other major stocks.
-
[BUSINESS] 2 sourcesC25 Index remains stable as Genmab shares surge
The C25 index closed stable at 1,916.01 on October 28, led by a 29.06 percent surge in Genmab shares.
Sources
npinvestor.dk · ugebrev.dk